alpesib_alpelisib150mg 28 tablets

alpesib_alpelisib150mg is a medication used to treat certain types of breast cancer. It is used together with fulvestrant. It is taken by mouth.
alpesib_alpelisib150mg is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.

In the European Union, alpesib_alpelisib150mg is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)‑positive, human epidermal growth factor receptor 2 (HER2)‑negative, locally advanced or metastatic breast cancer with a PIK3CA mutation after disease progression following endocrine therapy as monotherapy.

In April 2022, the indication for alpesib_alpelisib150mg was expanded in the US to include the treatment of severe manifestations of PIK3CA-related overgrowth spectrum (PROS) in those who require systemic therapy.

#Alecnib150mg_Alectinib_56Capsuls

#Acaluxen_100Mg_Acalabrutinib_60Capsules

#Alkixen_250 Mg_Crizotinib_60_Capsules

#Alpesib150mg_Alpelisib_28Tablets

#Avapag20 Mg_Avatrombopag_28Tablets

#Azarest300Mg_Azacitidine_14Tablets

#Caboxen20mg_Cabozantinib_90Capsules

#Caboxen80mg_Cabozantinib_30Capsules

#Capmaxen200 Mg_Capmatinib_56Tablets

#Daconib45Mg_Dacomitinib_30Tablets

#Elopag25mg_Eltrombopag_14Tablets

#Elopag50mg_Eltrombopag_14Tablets

#Eudaxen50 Mg_Diazoxide_100 Tablets

#Gilternib40Mg_Gilteritinib_90Tablets

#Hepanib200mg_Sorafenib_Tosylate200mg_28Tablets

#Ibruxen140_Ibrutinib_120Capsules

#Ivosenib250Mg_Ivosidenib_60Tablets

#Laronib100mg_Larotrectinib_30Capsules

#Laronib25mg_Larotrectinib_30Capsules

#Lenvaxen10mgLenvatinib_30Capsules

#LenvaxenmgLenvatinib_30Capsules

#Lorbrexen100mg_Lorlatinib_30Tablets

#Maviixen100_40Mg_Glecaprevir100mg_Pibrentasvir40mg_21Tablets

#Mobonib40Mg_Mobocertinib

#Niranib100mg_Niraparib_30Capsules

#Olanib150mg_Olaparib_120Capsules

#Olanib 50mg_Olaparib_112Capsules

#Osimert80mg_Osimertinib_30Tablets

#Palboxen125mg_Palbocilib_21Tablets

#Ponaxen15mg_Ponatinib_30Tablets

#Ponaxen45mg_Ponatinib_30Tablets

#Prostaxen60mg_Apalutamide_30Tablets

#Resiliva80mg_Resmetirom_30Tablets

#Selcaxen40mg_Selpercatinib_30Tablets

#Selinex20 Mg_Selinexor_16Tablets

#Sotoxen120mg_Sotorasib_56Tablets

#Tivoxen134Mg_Tivozanib_21Capsules

#Tofaxen5mg_Tofacitinib_14Tablets

#Tucaxen150mg_Tucatinib_30Tablets

#Ventoxen_100mg_Venteoclax_60Tablets

#Crizocent250mg_Crizotinib_60Capsules

#Ibrucent140mg_Ibrutinib_90Capsules

#Osicent80mg_Osimertinib_30Tablets

#Palbocent125_Palbociclib_21Capsuls

#Panovir_Sofosbuvir_Velpatasvir_28Tablets

#Tofacent5mg_Tofacitinib_60Tablets

#Barinib2Mg_Baricitinib-2Mg_30Tbs

#Barigen4Mg_Baricitinib_4Mg_30tablets